




Searching News Database: embryonic stem cell
HSMN NewsFeed - 12 Jul 2017
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
Asterias Biotherapeutics Completes Enrollment and Dosing of SCiStar Study's AIS-B 10 Million Cell Cohort
HSMN NewsFeed - 30 Jan 2015
Calithera Biosciences Appoints Keith Orford, M.D., Ph.D. to Vice President of Clinical Development
Calithera Biosciences Appoints Keith Orford, M.D., Ph.D. to Vice President of Clinical Development
HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
HSMN NewsFeed - 12 Dec 2013
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
HSMN NewsFeed - 1 Nov 2012
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
HSMN NewsFeed - 17 Oct 2011
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
HSMN NewsFeed - 7 Mar 2011
NeoStem Announces the Addition of Jason Kolbert as Vice President of Strategic Business Development
NeoStem Announces the Addition of Jason Kolbert as Vice President of Strategic Business Development
HSMN NewsFeed - 7 Sep 2010
NeoStem Appoints Distinguished Businessman as New President and Managing Director NeoStem China
NeoStem Appoints Distinguished Businessman as New President and Managing Director NeoStem China
HSMN NewsFeed - 29 Jul 2008
ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
HSMN NewsFeed - 14 May 2008
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team
HSMN NewsFeed - 8 May 2008
Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
HSMN NewsFeed - 25 Jan 2008
Dr. Thomas Okarma Resumes Direct Leadership of Geron's Oncology Drug Development Activities
Dr. Thomas Okarma Resumes Direct Leadership of Geron's Oncology Drug Development Activities
HSMN NewsFeed - 8 Jan 2008
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
HSMN NewsFeed - 4 Dec 2007
VistaGen Names Agustin de la Calle, Ph.D. as Vice President, Business Development
VistaGen Names Agustin de la Calle, Ph.D. as Vice President, Business Development
HSMN NewsFeed - 23 Oct 2007
BioTime Names Robert W. Peabody Senior Vice President and Chief Operating Officer
BioTime Names Robert W. Peabody Senior Vice President and Chief Operating Officer
HSMN NewsFeed - 1 Aug 2007
Advanced Cell Technology Enters Into Definitive Merger Agreement With Mytogen, Inc.
Advanced Cell Technology Enters Into Definitive Merger Agreement With Mytogen, Inc.
HSMN NewsFeed - 11 Jul 2007
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
HSMN NewsFeed - 5 Mar 2007
Stem Cell Innovations Names Ian Lyons, Ph.D., U.S. Chief Scientific Officer
Stem Cell Innovations Names Ian Lyons, Ph.D., U.S. Chief Scientific Officer
HSMN NewsFeed - 22 Feb 2007
VistaGen Therapeutics Names Dr. Matthew W. Kalnik as Executive Vice President
VistaGen Therapeutics Names Dr. Matthew W. Kalnik as Executive Vice President
HSMN NewsFeed - 13 Feb 2007
Healtheuniverse to Market and Commercialize Non-Embryonic Stem Cell Therapies Under the Brand Name Euphora
Healtheuniverse to Market and Commercialize Non-Embryonic Stem Cell Therapies Under the Brand Name Euphora
HSMN NewsFeed - 17 Jan 2007
Studies Show Geron's Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors
Studies Show Geron's Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors
HSMN NewsFeed - 16 Jan 2007
Pluristem Appoints Dr. William R. Prather as Senior VP of Corporate Development
Pluristem Appoints Dr. William R. Prather as Senior VP of Corporate Development
HSMN NewsFeed - 6 Nov 2006
Geron Licenses Antigen Targeting Patents for Cancer Vaccine Program from Immunomic Therapeutics
Geron Licenses Antigen Targeting Patents for Cancer Vaccine Program from Immunomic Therapeutics
HSMN NewsFeed - 22 Jun 2006
Geron Announces Collaboration to Develop Synthetic Surfaces for Growth of Embryonic Stem Cells
Geron Announces Collaboration to Develop Synthetic Surfaces for Growth of Embryonic Stem Cells
HSMN NewsFeed - 18 May 2006
Geron Names Laurence Elias, M.D., Vice President, Oncology Clinical Development
Geron Names Laurence Elias, M.D., Vice President, Oncology Clinical Development
Additional items found! 49

Members Archive contains
49 additional stories matching:
embryonic stem cell
(Password required)
embryonic stem cell
(Password required)